group4 infection & patient visibility
DESCRIPTION
Group4 Infection & Patient Visibility. Infection Case Study. Hip hemiarthroplasty after displaced femoral neck fracture: a survivorship analysis Femoral neck fracture – broken knee joint - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/1.jpg)
1
![Page 2: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/2.jpg)
Hip hemiarthroplasty after displaced femoral neck fracture: a survivorship analysis
• Femoral neck fracture – broken knee joint • Total Hip Arthroplasty – Yes….better results for patients than internal fixation and hemiarthroplasty.• Some Results for age group 60 + differ from this: “0-35 % dislocation cases” – quite highREASON ? Major one is comorbidities!
2
![Page 3: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/3.jpg)
Biomarkers as a Tool for Management of Immunosuppression in Transplant Patients
•Immuno-suppressive drugs•Without immunosuppression therapy, transplatation surgery could be fatal.•Therapeutic drug monitoring – DOES NOT reflect adverse effects to immune cells.•Pharmacodynamic monitoring (biomarkers)
3
![Page 4: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/4.jpg)
Problem of infection in the ICU
•Infections possible - ventilator-associated pneumonia, catheter-associated urinary tract infection, catheter-related bloodstream infection•Need to be attentive to horizontal infection
and use proper antibiotics for multi-resistant bacteria like MRSA.
4
![Page 5: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/5.jpg)
Managing infection in the critical care unit: how can infection control make the ICU safe?
Infection Control in the ICU
Device Related Nosocomial Infection In ICU
5
![Page 6: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/6.jpg)
6
Ventilator Associated Pneumonia
Antibiotic Resistance Pathogens
Catheter-related Infections
![Page 7: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/7.jpg)
Modifiable◦ Frequency of ventilator
circuit changes◦ Antibiotic usage
Nonmodifiable◦ Patient age and gender◦ Severity of illness◦ Coma
7
Bronchoscopic techniques
Nonbronchoscopic techniques
Balance between initial antibiotic and overuse
Risk Factors Prevention
![Page 8: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/8.jpg)
Decrease Infection in Neonatal Intensive Care Unit
8
![Page 9: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/9.jpg)
Long-Term Acute Care Hospital
9
![Page 10: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/10.jpg)
VAP rate per 1,000 device days
CR-BSI rate per 1,000 device days
Year 1997 2004 2002 2004
Medical ICU 29 18 8.2 3.4
Surgical ICU Similar declines 10.5 4.5
Burn Center Similar declines 9.5 1.85
10
Bundle Methodology
VAP: Ventilator-Associated PneumoniaCR-BSIs: Catheter-Related Bloodstream Infections
Pursuing perfection in fighting with VAP and CR-BSIs in ICU
![Page 11: Group4 Infection & Patient Visibility](https://reader036.vdocument.in/reader036/viewer/2022062500/56815150550346895dbf73b5/html5/thumbnails/11.jpg)
11